With headquarters in China and manufacturing and R&D facilities in both China and the United States, Raybow PharmaScience is a leading contract development and manufacturing organization (CDMO) focused on green chemistry. The company has passed official audits from regulatory bodies such as the USFDA, CFDA, and AIFA/PMDA. Raybow's Taizhou and Suzhou sites are equipped with advanced environmental protection treatment systems, allowing for the reuse and recirculation of certain chemicals used in pharmaceutical production. The company's R&D team, consisting of experienced chemists, is dedicated to the research and development of new pharmaceutical technologies, including flow chemistry, high-end fluorine chemistry, asymmetric chiral synthesis, glycosides, and biological enzyme technology. Raybow also has business offices in Europe and North America, serving customers worldwide.